Skip to main content
Equibles

Kyle Carver

CFO

Evommune, Inc. (EVMN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Evommune, Inc. publishes a filing, an earnings call transcript or a press release.

Get EVMN alerts

About Kyle Carver

Kyle Carver is recorded as CFO at Evommune, Inc. (EVMN). The newest filing on record that lists Kyle Carver as CFO at Evommune, Inc. (EVMN) is dated April 21, 2026. The proxy statement of Evommune, Inc. reports total compensation of $4,404,643 for Kyle Carver in fiscal 2025, including a base salary of $501,875. Disclosed compensation is on record for 2 fiscal years. Kyle Carver has spoken on 1 investor event across 1 company, most recently for Evommune, Inc. on April 13, 2026. Evommune, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Evommune, Inc. includes Luis Peña (CEO and Board Member) and Eugene A. Bauer (Board Member).

Kyle Carver on recent calls

“Hello everyone, and thank you for joining us for today's webinar, highlighting the role of MRGPRX2 in migraine. My name is Kyle Carver, Chief Financial Officer at Evamune.”
CFO, KOL Webinar Highlighting Role of MRGPRX2 in Migraine ·

Affiliation history

Company network

Leadership on record at Evommune, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Evommune, Inc. (EVMN) $501,875 $4,404,643
2024 Evommune, Inc. (EVMN) $470,000 $1,237,071

Recent activity